Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
Leukemia
|
June 26, 2021
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P Steensma, Martin Wermke, Virginia M Klimek, et al.
Blood Cancer Discovery
|
January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Blood
|
July 12, 2024
Risk prediction for clonal cytopenia: multicenter real-world evidence
Zhuoer Xie, Rami Komrokji, Najla Al Ali, et al.
Leukemia
|
April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
American Journal of Hematology
|
June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
The Lancet. Haematology
|
June 22, 2020
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
Amer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, et al.
Blood Cancer Journal
|
June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database
Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Hemasphere
|
June 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)
Giulia Maggioni, Gabriele Todisco, Elisabetta Sauta, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
Leukemia
|
June 26, 2021
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P Steensma, Martin Wermke, Virginia M Klimek, et al.
Blood Cancer Discovery
|
January 26, 2026
Incorporation of genomic determinants improves diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia
Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla, et al.
Blood
|
July 12, 2024
Risk prediction for clonal cytopenia: multicenter real-world evidence
Zhuoer Xie, Rami Komrokji, Najla Al Ali, et al.
Leukemia
|
April 30, 2026
How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?
Maria Julia Montoro, Pamela Acha, Claudia Haferlach, et al.
American Journal of Hematology
|
June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
The Lancet. Haematology
|
June 22, 2020
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
Amer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, et al.
Blood Cancer Journal
|
June 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database
Jan Philipp Bewersdorf, Tariq Kewan, Luca Lanino, et al.
Hemasphere
|
June 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)
Giulia Maggioni, Gabriele Todisco, Elisabetta Sauta, et al.
Page
of 15